Archives
-
25-Hydroxycholesterol Reprograms Tumor Macrophages
2026-10-07
Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint in tumor-associated macrophages. Their findings connect lysosomal lipid accumulation to GPR155–mTORC1 signaling, AMPKα activation, STAT6 phosphorylation, and immunosuppressive ARG1 production, while showing that CH25H targeting can improve antitumor immune responses in experimental models.
-
FLAG Tag Peptide in DNA Polymerase Research
2026-10-07
The FLAG tag Peptide (DYKDDDDK) is a compact epitope tag used conceptually for recombinant protein detection and affinity-based purification. In contrast, ter Beek et al. provided structural, biochemical, and genetic evidence that an Fe–S cluster in the catalytic core of yeast DNA polymerase ε is required for polymerase activity and cell viability. The supplied evidence does not show that FLAG peptide was used in that study, so any connection is methodological rather than a reported finding.
-
Safe DNA Gel Stain: Evidence and Limits
2026-10-06
Safe DNA Gel Stain is a DNA and RNA gel stain for fluorescent nucleic acid visualization in agarose and acrylamide gels. The product page supports blue-light compatibility and reported spectral properties, but independent evidence for reduced mutagenicity, DNA damage reduction during gel imaging, or cloning efficiency improvement is not provided.
-
HyperPFU Polymerase in LIDAR Research Context
2026-10-06
A source-grounded overview of HyperPFU high-fidelity DNA polymerase claims and their conceptual relevance to DNA-encoded synthetic receptor research, alongside the published findings, evidence strength and limitations of the LIDAR platform.
-
293T Cells in Multiplex CRISPR Research
2026-10-05
293T Cells provide a useful mammalian context for interpreting multiplex CRISPR experiments, but they should not be mistaken for a universal disease model. This article explains how to separate delivery, editing, cellular stress, and biological relevance when evaluating genome-engineering evidence.
-
PHF2, Neuroinflammation, and Alzheimer’s Disease
2026-10-05
A 2025 Molecular Psychiatry study identifies the histone demethylase PHF2 as a regulator of inflammatory gene expression in Alzheimer’s disease models. Its combination of human observations, genomic profiling, genetic perturbation, synaptic analysis, and behavioral testing links PHF2 activity with neuroinflammation and memory-related outcomes, while leaving therapeutic translation for future studies.
-
HyperScribe™ Poly (A) Tailing Kit: Evidence Overview
2026-10-04
A source-grounded overview of the HyperScribe™ Poly (A) Tailing Kit, examining its enzymatic rationale, conceptual research applications, evidence provenance, and limitations without presenting experimental procedures.
-
ECE-1c Stability and Silmitasertib in Lung Cancer
2026-10-01
Almarza and colleagues identify ECE-1c stability as a mechanistic link between CK2 activity, cancer stem cell-like traits, cisplatin resistance, and invasive behavior in non-small cell lung cancer models. Their Lys-6 mutation strategy and pharmacologic CK2 perturbation support ECE-1c as a candidate biomarker and Silmitasertib as a tool for testing this pathway, while leaving clinical efficacy and patient-level relevance to future studies.
-
H-89 for PKA and cAMP Signaling Studies
2026-10-01
H-89 provides an acute pharmacological way to test whether PKA contributes to cAMP-linked signaling, Wnt-driven osteoblast metabolism, proliferation, or apoptosis. Its greatest value comes from pairing concentration-response experiments with pathway-specific readouts, viability controls, and orthogonal validation rather than treating a single cellular dose as proof of PKA selectivity.
-
Berberrubine and NAFLD: Metabolic and Microbiota Insights
2026-09-30
The reference study identifies berberrubine, a major berberine metabolite, as an active mediator of improved hepatic steatosis and insulin resistance in high-fat diet mice and oleic acid-treated HepG2 cells. Its integrated analysis of metabolic proteins and gut microbiota provides a useful framework for distinguishing metabolite-specific activity from the effects of the parent compound.
-
Modified Ethanol-Injected mRNA Lipoplexes as Tumour Vaccines
2026-09-30
The 2024 Journal of Drug Targeting study optimized PEGylation of cationic mRNA lipoplexes made by a modified ethanol injection method. A 3 mol% PEG-Chol formulation reduced erythrocyte agglutination and lung accumulation while supporting strong anti-OVA antibody responses, cytotoxic activity, and tumour-growth suppression after intravenous vaccination in mice.
-
Cholesterol (B1702) for Reliable Cell Assays
2026-09-29
Learn how Cholesterol, SKU B1702, can improve the interpretability of membrane, viability, proliferation, and lipid metabolism experiments through controlled formulation and storage practices. This scenario-based guide connects practical assay design with evidence from localized mRNA–LNP research while distinguishing established product specifications from workflow recommendations.
-
(R)-MG132: A Rigorous Proteasome Negative Control
2026-09-29
Learn how (R)-MG132 (SKU C3348) strengthens proteasome inhibition validation in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers assay design, handling, interpretation, vendor selection, and connections to current cancer-metabolism research.
-
Isoprenaline Hydrochloride: Research Workflows
2026-09-28
Isoprenaline Hydrochloride, also known as isoproterenol, provides a controllable way to model β-adrenergic stimulation across cardiac, neurobehavioral, airway, and endothelial assays. This guide translates recent heart–brain research into practical workflows, assay controls, and troubleshooting strategies.
-
Triiodothyronine (T3) and Precision Cell Models
2026-09-28
A translational framework for studying Triiodothyronine (T3) alongside precision gene editing—without conflating thyroid hormone signaling with the mechanisms of base editing.